Skip to content

AFFiRiS AG vs Vaxxinity

AFFiRiS AG logo

AFFiRiS AG

Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you

2 employees · est. 2003 · Wien, Austria

VS
Vaxxinity logo

Vaxxinity

Our mission is to democratize health by pioneering the third biologic revolution

44 employees · est. 2019 · United States

AFFiRiS AG is the older company (2003 vs 2019); Vaxxinity is the larger of the two.

Side-by-Side Comparison

AFFiRiS AG Vaxxinity
Founded
2003 older 2019
Headquarters
Wien, Austria United States
Employees
2 44 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Pharmaceutical
Funding Stage
Not tracked yet Grant
Total Funding
$47.00M $9.25M
Funding Rounds
4 2
Taxonomy
ImmunotherapyNeurodegenerative DiseasesParkinson's DiseaseAlzheimer's DiseaseMultiple System AtrophyDementia With Lewy Bodies +9 VaccinesChronic DiseasesInfectious DiseasesSynthetic Peptide VaccinesAlzheimer'sParkinson's +7
Website
affiris.com vaxxinity.com
AFFiRiS AG logo

About AFFiRiS AG

AFFiRiS AG is a clinical-stage biotechnology company based in Austria, founded in 2003. The company's slogan, "Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you," encapsulates their mission to challenge established treatment options for neurode...

Vaxxinity logo

About Vaxxinity

Vaxxinity is a U.S.-based global biotechnology company that is pioneering a new class of medicines with the mission to democratize health. The company is headquartered in Dallas, TX and has operations in the United States, Latin America, Europe, and Asia. Vaxxinity's proprietary technology platform...

Also comparing in this category

Comparing more than these two?

Get AFFiRiS AG, Vaxxinity and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does AFFiRiS AG compare?

A PDF of AFFiRiS AG and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

AFFiRiS AG was founded in 2003, based in Wien, Austria, with 2 employees. AFFiRiS AG is a clinical-stage biotechnology company based in Austria, founded in 2003. The company's slogan, "Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. Vaxxinity was founded in 2019, based in United States, with 44 employees. Vaxxinity is a U.S.-based global biotechnology company that is pioneering a new class of medicines with the mission to democratize health. The company is headquartered in Dallas, TX and has operations.
AFFiRiS AG has raised $47.00M and Vaxxinity $9.25M. Latest stage: Vaxxinity Grant.
Both work in Biotechnology and Pharmaceutical.

Compare AFFiRiS AG with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AFFiRiS AG on 28 May 2026, and Vaxxinity on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout